Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Development of the Swiss Database for dosing medicinal products in pediatrics.
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID 4634825
Author(s) Tilen, Romy; Panis, Dalibor; Aeschbacher, Samuel; Sabine, Thomas; Meyer Zu Schwabedissen, Henriette E; Berger, Christoph
Author(s) at UniBasel Meyer zu Schwabedissen, Henriette
Tilen, Romy
Year 2022
Title Development of the Swiss Database for dosing medicinal products in pediatrics.
Journal European journal of pediatrics
Volume 181
Number (3)
Pages / Article-Number 1221-1231
Keywords Children; Drug safety; Off-label use; Prescribing; Web-based software

In daily paediatrics, drugs are commonly used off-label, as they are not approved for children. Approval is lacking because the required clinical studies were limited to adults in the past. Without clinical studies, evidence-based recommendations for drug use in children are limited. Information on off-label drug dosing in children can be found in different handbooks, databases and scientific publications but the dosing recommendations can differ considerably. To improve safety and efficacy of drugs prescribed to children and to assist the prescribers, stakeholders in Swiss paediatrics started a pilot project, supported by the Federal Office of Public Health, with the aim to create a database, providing healthcare professionals with so called "harmonised" dosage recommendations based on the latest available scientific evidence and best clinical practice. A standardised process for dosage harmonisation between paediatric experts was defined, guided and documented in an electronic tool, developed for this purpose. As proof of principle, a total of 102 dosage recommendations for 30 different drugs have been nationally harmonised in the pilot phase considering the current scientific literature and the approval of the most experienced national experts in the field.Conclusion: This approach paved the way for unified national dosage recommendations for children. Reaching the project's milestones fulfilled the prerequisites for funding and starting regular operation of SwissPedDose in 2018. Since then, the database was extended with recommendations for 100 additional drugs. What is Known: • Prescribing off-label is a common practice among paediatricians, as many drugs are still not authorised for use in children. • Some countries developed national drug formularies providing off-label dosage recommendations. What is New: • Comparison of published dosage recommendations in known drug handbooks and online databases show substantial differences and heterogeneity, revealing the need for harmonisation. • The design of a tool for standardised harmonisation of dosage recommendations, based on information collected on currently applied dosages, latest scientific evidence and the approval of experts.

ISSN/ISBN 1432-1076
Full Text on edoc
Digital Object Identifier DOI 10.1007/s00431-021-04304-8
PubMed ID

MCSS v5.8 PRO. 0.345 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |